Product Information
VORICONAZOLE 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.8846 per EA under NDC 65862089230. Its NADAC has been published 529 times since Aug 17, 2016.
FDA first approved this application on Jan 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862089230
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VORICONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA206837FDA Approved
1/22/2016
TE Code
AB
On Market Since
1/22/2016
Pharmacological Classes
Price Statistics
The NADAC for VORICONAZOLE 200 MG TABLET has been published 529 times since Aug 17, 2016, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8846 per EA |
|---|---|
| All-time high | $15.0470 (Oct 12, 2016) |
| All-time low | $1.3268 (Sep 20, 2023) |
| 52-week high | $2.2348 |
| 52-week low | $1.7468 |
| Median price | $2.9326 |
| Average price | $4.2579 |
| Largest weekly change | -61.5% (Jun 23, 2021) |
| Weeks tracked | 529 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Voriconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VORICONAZOLE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VORICONAZOLE 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.8846 per EA (NDC 65862089230), effective Sep 30, 2026.
How has the price of VORICONAZOLE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for VORICONAZOLE 200 MG TABLET has declined 87.4%. It has been tracked across 529 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for VORICONAZOLE 200 MG TABLET?
Since Aug 17, 2016, the NADAC for VORICONAZOLE 200 MG TABLET has ranged from a low of $1.3268 (Sep 20, 2023) to a high of $15.0470 (Oct 12, 2016), with a median of $2.9326 per EA.
Are there cheaper alternatives to VORICONAZOLE 200 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VORICONAZOLE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VORICONAZOLE 200 MG TABLET?
VORICONAZOLE 200 MG TABLET (NDC 65862089230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.